Theradiag SA
PAR:ALTER

Watchlist Manager
Theradiag SA Logo
Theradiag SA
PAR:ALTER
Watchlist
Price: 1.26 EUR Market Closed
Market Cap: 16.4m EUR
Have any thoughts about
Theradiag SA?
Write Note

Intrinsic Value

ALTER's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one ALTER stock under the Base Case scenario is 1.36 EUR. Compared to the current market price of 1.26 EUR, Theradiag SA is Undervalued by 7%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ALTER Intrinsic Value
1.36 EUR
Undervaluation 7%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Theradiag SA

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for ALTER cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about ALTER?
Bearish
Neutral
Bullish

Fundamental Analysis

1.26 EUR
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Theradiag SA
FR
Health Care
Market Cap
16.4m EUR
IPO
Dec 11, 2012
Employees
60
France
Market Cap
16.4m EUR
Industry
Health Care
IPO
Dec 11, 2012
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Theradiag SA

Provide an overview of the primary business activities
of Theradiag SA.

What unique competitive advantages
does Theradiag SA hold over its rivals?

What risks and challenges
does Theradiag SA face in the near future?

Has there been any significant insider trading activity
in Theradiag SA recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Theradiag SA.

Provide P/S
for Theradiag SA.

Provide P/E
for Theradiag SA.

Provide P/OCF
for Theradiag SA.

Provide P/FCFE
for Theradiag SA.

Provide P/B
for Theradiag SA.

Provide EV/S
for Theradiag SA.

Provide EV/GP
for Theradiag SA.

Provide EV/EBITDA
for Theradiag SA.

Provide EV/EBIT
for Theradiag SA.

Provide EV/OCF
for Theradiag SA.

Provide EV/FCFF
for Theradiag SA.

Provide EV/IC
for Theradiag SA.

Show me price targets
for Theradiag SA made by professional analysts.

What are the Revenue projections
for Theradiag SA?

How accurate were the past Revenue estimates
for Theradiag SA?

What are the Net Income projections
for Theradiag SA?

How accurate were the past Net Income estimates
for Theradiag SA?

What are the EPS projections
for Theradiag SA?

How accurate were the past EPS estimates
for Theradiag SA?

What are the EBIT projections
for Theradiag SA?

How accurate were the past EBIT estimates
for Theradiag SA?

Compare the revenue forecasts
for Theradiag SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Theradiag SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Theradiag SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Theradiag SA compared to its peers.

Compare the P/E ratios
of Theradiag SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Theradiag SA with its peers.

Analyze the financial leverage
of Theradiag SA compared to its main competitors.

Show all profitability ratios
for Theradiag SA.

Provide ROE
for Theradiag SA.

Provide ROA
for Theradiag SA.

Provide ROIC
for Theradiag SA.

Provide ROCE
for Theradiag SA.

Provide Gross Margin
for Theradiag SA.

Provide Operating Margin
for Theradiag SA.

Provide Net Margin
for Theradiag SA.

Provide FCF Margin
for Theradiag SA.

Show all solvency ratios
for Theradiag SA.

Provide D/E Ratio
for Theradiag SA.

Provide D/A Ratio
for Theradiag SA.

Provide Interest Coverage Ratio
for Theradiag SA.

Provide Altman Z-Score Ratio
for Theradiag SA.

Provide Quick Ratio
for Theradiag SA.

Provide Current Ratio
for Theradiag SA.

Provide Cash Ratio
for Theradiag SA.

What is the historical Revenue growth
over the last 5 years for Theradiag SA?

What is the historical Net Income growth
over the last 5 years for Theradiag SA?

What is the current Free Cash Flow
of Theradiag SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Theradiag SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Theradiag SA

Current Assets 10.6m
Cash & Short-Term Investments 5.7m
Receivables 2.4m
Other Current Assets 2.6m
Non-Current Assets 3.8m
Long-Term Investments 470k
PP&E 240k
Intangibles 3.1m
Current Liabilities 2.5m
Accounts Payable 1.5m
Accrued Liabilities 890k
Other Current Liabilities 90k
Non-Current Liabilities 1.6m
Long-Term Debt 1.6m
Efficiency

Earnings Waterfall
Theradiag SA

Revenue
12.6m EUR
Cost of Revenue
-2.6m EUR
Gross Profit
10.1m EUR
Operating Expenses
-9.4m EUR
Operating Income
690k EUR
Other Expenses
-270k EUR
Net Income
420k EUR

Free Cash Flow Analysis
Theradiag SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ALTER Profitability Score
Profitability Due Diligence

Theradiag SA's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROIC is Increasing
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
44/100
Profitability
Score

Theradiag SA's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

ALTER Solvency Score
Solvency Due Diligence

Theradiag SA's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Negative Net Debt
Long-Term Solvency
85/100
Solvency
Score

Theradiag SA's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ALTER Price Targets Summary
Theradiag SA

There are no price targets for ALTER.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ALTER?

Click here to dive deeper.

Dividends

Theradiag SA
does not pay dividends
Shareholder Yield

Current shareholder yield for ALTER is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ALTER Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one ALTER stock?

The intrinsic value of one ALTER stock under the Base Case scenario is 1.36 EUR.

Is ALTER stock undervalued or overvalued?

Compared to the current market price of 1.26 EUR, Theradiag SA is Undervalued by 7%.

Back to Top